Gadolinium,[5,8-bis[(carboxy-kO)methyl]-11-[2-(methylamino)-2-(oxo-kO)ethyl]-3-(oxo-kO)-2,5,8,11-tetraazatridecan-13-oato(3-)-kN5,kN8,kN11,kO13]-

CAS: 131410-48-5

Ref. IN-DA00HSGI

Informação sobre produto

• Nome: Gadolinium,[5,8-bis[(carboxy-kO)methyl]-11-[2-(methylamino)-2-(oxo-kO)ethyl]-3-(oxo-kO)-2,5,8,11-tetraazatridecan-13-oato(3-)-kN5,kN8,kN11,kO13]-
• Sinónimos: [u'gadodiamide', u'Gd-DTPA bis-(methylamide)', u'Gd-DTPA-BMA', u'Omniscan', u'Omniscan Unique Softpack', u'gadodiamide', u'131410-48-5', u'UNII-84F6U3J2R6', u'Omniscan (TN)', u'C16H26GdN5O8.xH2O', u'84F6U3J2R6', u'AC1L4BCU', u'Gadodiamide (USP/INN)', u'SCHEMBL73031', u'C16H26N5O8.Gd', u'MOLI001033', u'3688AH', u'AC-925', u'AKOS015900642', u'VA10992', u'SC-19852', u'TL8000744', u'D04284', u'A806259', u'J-004857', u'2-[bis[2-[[2-(methylamino)-2-oxidanylidene-ethyl]-(2-oxidanidyl-2-oxidanylidene-ethyl)amino]ethyl]amino]ethanoate; gadolinium(3+)', u'2-[bis[2-[[2-(methylamino)-2-oxoethyl]-(2-oxido-2-oxoethyl)amino]ethyl]amino]acetate; gadolinium(3+)', u'2-[bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxoethyl]amino]ethyl]amino]acetate; gadolinium(3+)', u'2-[bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxoethyl]amino]ethyl]amino]acetate;gadolinium(3+)', u'gadolinium(III) 5,8-bis(carboxylatomethyl)-11-(2-(methylamino)-2-oxoethyl)-3-oxo-2,5,8,11-tetraazatridecan-13-oate', u'Omniscan', u'Gadodiamida', u'Gadodiamidum', u'Gadodiamide hydrate', u'Gadodiamide [USP]', u'Gadolinium-DTPA-BMA', u'GDDTPA-BMA', u'Gd DTPA-BMA', u'Gadodiamidum [INN-Latin]', u'D03EEH', u'UNII-0RPE15QPL0', u'Gadodiamida [INN-Spanish]', u'C16H26GdN5O8', u'C16H28GdN5O9.xH2O', u'Gadodiamide [USAN:USP:INN]', u'HSDB 7547', u'Dv-7572', u'CID153921', u'CS-O-01566', u'DV 7572', u'C16-H28-Gd-N5-O9.x-H2-O', u'S 041', u'S-041', u'A10415', u'gadolinium diethylenetriamine pentaacetic acid bismethylamide', u'122795-43-1', u'gadolinium(III) 5,8-bis(carboxylatomethyl)-2-(2-(methylamino)-2-oxoethyl)-10-oxo-2,5,8,11-tetraazadodecane-1-carboxylate', u'Gadolinium, (5,8-bis((carboxy-kappaO)methyl)-11-(2-(methylamino)-2-(oxo-kappaO)ethyl)-3-(oxo-kappaO)-2,5,8,11-tetraazatridecan-13-oato(3-)-kappaN5,kappaN8,kappaN11,kappaO13)-'], 2,5,8,11-Tetraazatridecan-13-oic acid, 5,8-bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-, gadolinium complex, Dv 7572, Gadodiamide (500 Mg), Gadolinium 2-[Bis[2-(Carboxylatomethyl-(Methylcarbamoylmethyl)Amino)Ethyl]Amino]Acetate, Gadolinium 5,8-Bis(Carboxylatomethyl)-11-[2-(Methylamino)-2-Oxoethyl]-3-Oxo-2,5,8,11-Tetraazatridecan-13-Oate (Non-Preferred Name), Gadolinium, [5,8-bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-)]-, Gadolinium, [5,8-bis[(carboxy-κO)methyl]-11-[2-(methylamino)-2-(oxo-κO)ethyl]-3-(oxo-κO)-2,5,8,11-tetraazatridecan-13-oato(3-)-κN⁵,κN⁸,κN¹¹,κO¹³]-, Gadolinium-DTPA-BMA, Gd-DTPA-BMA, Omniscan, S-041, [5,8-Bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraaza-tridecan-13-oato(3-)]gadolinium, [5,8-Bis[(carboxy-κO)methyl]-11-[2-(methylamino)-2-(oxo-κO)ethyl]-3-(oxo-κO)-2,5,8,11-tetraazatridecan-13-oato(3-)-κN⁵,κN⁸,κN¹¹,κO¹³]gadolinium, [5,8-Bis[(carboxy-κO)methyl]-11-[2-(methylamino)-2-(oxo-κO)ethyl]-3-(oxo-κO)-2,5,8,11-tetraazatridecan-13-oato(3-)-κN5,κN8,κN11,κO13]gadolinium, Gadolinium, [5,8-bis[(carboxy-κO)methyl]-11-[2-(methylamino)-2-(oxo-κO)ethyl]-3-(oxo-κO)-2,5,8,11-tetraazatridecan-13-oato(3-)-κN5,κN8,κN11,κO13]-
• Marca: Indagoo

Propriedades químicas

• Peso molecular: 573.6563
• Fórmula: C₁₆H₂₆GdN₅O₈
• Pureza: 99%
• Cor/forma: Solid
• InChI: InChI=1S/C16H29N5O8.Gd/c1-17-12(22)7-20(10-15(26)27)5-3-19(9-14(24)25)4-6-21(11-16(28)29)8-13(23)18-2;/h3-11H2,1-2H3,(H,17,22)(H,18,23)(H,24,25)(H,26,27)(H,28,29);/q;+3/p-3
• Chave InChI: HZHFFEYYPYZMNU-UHFFFAOYSA-K